ENTELLIGENCE, in partnership with Actelion Pharmaceuticals US, supports basic science, translational, and clinical research in the field of cardiopulmonary medicine.
To that end, the organization is accepting applications for its thirteenth annual Young Investigator grant program. Established in 2005, the program provides opportunities for promising young investigators to promote quality medical care and enhance patients’ lives through support for research (basic science, clinical, or translational) in the area of pulmonary hypertension, with a specific focus on expanding knowledge of pulmonary vascular pathobiology pathways.
In 2018, the program will award a a single one-year grant of up to $100,000 for a mentored project.
Eligible applicants include junior faculty members (up to and including the rank of assistant professor), postdoctoral students, research assistants, doctoral candidates, and fellows in the United States and Canada.
Letters of Intent must be received no later than November 2, 2017. Upon review, selected applicants will be invited to submit a full application by February 19, 2018.
For complete program guidelines and application instructions, see the ENTELLIGENCE website.
For more information, please visit: http://entelligencemd.org/sites/default/files/ENTELLIGENCE-Invitation.pdf
- Basic Science
- Cardiovascular
- Clinical Science
- Pulmonology
- Junior Faculty
- New Investigator
- PhD Students
- Postdoc/Residents/Fellows